Compounds > organophosphonates
Page last updated: 2024-09-05

organophosphonates and Hypercholesterolemia

organophosphonates has been researched along with Hypercholesterolemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boyer, SH; Cable, EE; Erion, MD; Fujitaki, JM; Godwin, JL; Hecker, SJ; Hou, J; Jacintho, JD; Jiang, H; Li, H; Li, W; Reddy, MV; Schulz, WG; Wu, R1
Cable, EE; Chi, B; Erion, MD; Fujitaki, JM; Ito, BR; Linemeyer, DL; MacKenna, DA; Song, X; van Poelje, PD; Wilker, CE; Zhang, BH1
Caniggia, A; Gennari, C; Picchi, M1

Other Studies

3 other study(ies) available for organophosphonates and Hypercholesterolemia

ArticleYear
Synthesis and biological evaluation of a series of liver-selective phosphonic acid thyroid hormone receptor agonists and their prodrugs.
    Journal of medicinal chemistry, 2008, Nov-27, Volume: 51, Issue:22

    Topics: Animals; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Glycerolphosphate Dehydrogenase; Hypercholesterolemia; Ligands; Liver; Molecular Structure; Organophosphonates; Prodrugs; Rats; Rats, Sprague-Dawley; Receptors, Thyroid Hormone; Stereoisomerism; Structure-Activity Relationship

2008
Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys.
    British journal of pharmacology, 2009, Volume: 156, Issue:3

    Topics: Animals; Anticholesteremic Agents; Atorvastatin; Cholesterol; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Heptanoic Acids; Hypercholesterolemia; Macaca fascicularis; Male; Organophosphonates; Phenols; Prodrugs; Pyrroles; Rabbits; Thyroid Hormone Receptors beta

2009
[Diphosphonate (disodium etidronate) lowers cholesterol and total lipid levels in the blood of humans].
    Bollettino della Societa italiana di biologia sperimentale, 1974, Sep-15, Volume: 50, Issue:17

    Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Etidronic Acid; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Organophosphonates; Organophosphorus Compounds

1974